Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bridge over troubled waters: Understanding the synthetic and biological identities of engineered nanomaterials
Karolinska Institutet, Stockholm, Sweden. (Hans Hertz)ORCID iD: 0000-0003-3095-0608
Show others and affiliations
2013 (English)In: Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, ISSN 1939-5116, E-ISSN 1939-0041, Vol. 5, no 2, p. 111-129Article in journal (Refereed) Published
Abstract [en]

Engineered nanomaterials offer exciting opportunities for 'smart' drug delivery and in vivo imaging of disease processes, as well as in regenerative medicine. The ability to manipulate matter at the nanoscale enables many new properties that are both desirable and exploitable, but the same properties could also give rise to unexpected toxicities that may adversely affect human health. Understanding the physicochemical properties that drive toxicological outcomes is a formidable challenge as it is not trivial to separate and, hence, to pinpoint individual material characteristics of nanomaterials. In addition, nanomaterials that interact with biological systems are likely to acquire a surface corona of biomolecules that may dictate their biological behavior. Indeed, we propose that it is the combination of material-intrinsic properties (the 'synthetic identity') and context-dependent properties determined, in part, by the bio-corona of a given biological compartment (the 'biological identity') that will determine the interactions of engineered nanomaterials with cells and tissues and subsequent outcomes. The delineation of these entwined 'identities' of engineered nanomaterials constitutes the bridge between nanotoxicological research and nanomedicine.

Place, publisher, year, edition, pages
Wiley , 2013. Vol. 5, no 2, p. 111-129
National Category
Other Medical Sciences
Identifiers
URN: urn:nbn:se:kth:diva-259169DOI: 10.1002/wnan.1206ISI: 000318028800001PubMedID: 23335558Scopus ID: 2-s2.0-84873744324OAI: oai:DiVA.org:kth-259169DiVA, id: diva2:1350693
Note

QC 20190917

Available from: 2019-09-12 Created: 2019-09-12 Last updated: 2019-09-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Vogt, Carmen Mihaela
In the same journal
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Other Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf